Moreover, pre-treatment of BCL6-independent GCB-DLBCL cell line OCI-Ly4 with ABT-737 failed to sensitize them to RI-BPI (Fig. S2B), suggesting that BCL2 function is not involved in conferring baseline sensitivity to RI-BPI. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.